Assessing Influence of HIV Status on Management outcomes of Drug Sensitive Pulmonary Tuberculosis in the Bo District of Southern Sierra Leone.
International Journal of Health Sciences · 2023
DOI: 10.47941/ijhs.1257 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Health Sciences, 2023. Verfasst von Tommy Allieu.
Abstract (Originalsprache)
Purpose: Tuberculosis in Human immunodeficiency virus is a predictor of unfavourable outcome during the management of TB cases due to the synergy both bear in the patient. This study is to test the hypothesis that patient is more likely to be unfavourable in the co infected than the TB stand-alone patients with standard treatment in patients. The associated factors might not be exhaustive that leads to outcomes factored in the study. Methodology: The retrospective cohort study data of 1,947 patients admitted from 1st January 2020 to 1st January 2022 at TB treatment centres in Bo district of Sierra Leone was analysed using datatab software after data completeness was checked and cleaned. Both bi-variable and multi-variable logistics regression and other statistical methods were employed to assess the relationship between HIV+TB synergic as well as TB alone outcomes. Data was analysed based on 95% CI and p
Zitieren
APA
Allieu, T. (2023). Assessing Influence of HIV Status on Management outcomes of Drug Sensitive Pulmonary Tuberculosis in the Bo District of Southern Sierra Leone. International Journal of Health Sciences. https://doi.org/10.47941/ijhs.1257
Vancouver
Allieu T. Assessing Influence of HIV Status on Management outcomes of Drug Sensitive Pulmonary Tuberculosis in the Bo District of Southern Sierra Leone. International Journal of Health Sciences. 2023. doi:10.47941/ijhs.1257
BibTeX
@article{Allieu2023,
author = {Allieu, Tommy},
title = {Assessing Influence of HIV Status on Management outcomes of Drug Sensitive Pulmonary Tuberculosis in the Bo District of Southern Sierra Leone},
journal = {International Journal of Health Sciences},
year = {2023},
doi = {10.47941/ijhs.1257}
}
EUVIMED